Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why

28.10.24 23:00 Uhr

Werte in diesem Artikel
Aktien

112,20 EUR 1,05 EUR 0,94%

Indizes

5.930,9 PKT 63,8 PKT 1,09%

Cardinal Health (CAH) closed the most recent trading day at $110.87, moving -0.02% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.27%. At the same time, the Dow added 0.65%, and the tech-heavy Nasdaq gained 0.26%.The prescription drug distributor's stock has climbed by 1% in the past month, exceeding the Medical sector's loss of 4.14% and lagging the S&P 500's gain of 2%.Market participants will be closely following the financial results of Cardinal Health in its upcoming release. The company plans to announce its earnings on November 1, 2024. The company is expected to report EPS of $1.64, down 5.2% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $51.26 billion, down 6.4% from the prior-year quarter.Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.61 per share and revenue of $215.84 billion, indicating changes of +1.06% and -4.91%, respectively, compared to the previous year.Investors should also take note of any recent adjustments to analyst estimates for Cardinal Health. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. As of now, Cardinal Health holds a Zacks Rank of #2 (Buy).Digging into valuation, Cardinal Health currently has a Forward P/E ratio of 14.57. This signifies a discount in comparison to the average Forward P/E of 16.65 for its industry.We can also see that CAH currently has a PEG ratio of 1.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Dental Supplies was holding an average PEG ratio of 1.78 at yesterday's closing price.The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 100, this industry ranks in the top 40% of all industries, numbering over 250.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Cardinal

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Cardinal Health Inc.

Analysen zu Cardinal Health Inc.

DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst
03.11.2015Cardinal Health BuyUBS AG
03.11.2015Cardinal Health OutperformFBR Capital
09.06.2015Cardinal Health BuyUBS AG
10.03.2015Cardinal Health OutperformFBR Capital
04.03.2015Cardinal Health OutperformRBC Capital Markets
DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"